The key takeaway: it all comes back to Glutathione
Reconstitution and Administration Routes Discussed in Literature GHK-Cu administration in literature includes topical creams, gels, wound dressings, microneedle-assisted delivery models, liposomal formulations, and injectable-route regulatory discussion [2], [7], [8], [14], [15]
When taken as directed by a healthcare professional, it is generally well tolerated
If you experience redness, peeling, or severe dryness, scale back the usage frequency or stop using one of the products temporarily
Many of these growth factors are also known to be involved in mechanisms of resistance to endocrine therapies for the treatment of breast and prostate cancer (Schiff et al., 2003)
This estimate is derived from comparative pharmacology and peptide absorption literature rather than from direct human studies: What This Means If you take 10 mg orally, approximately 3.8 mg reaches systemic circulation The remaining 6.2 mg is metabolized by stomach acid, proteases, and first-pass liver metabolism before reaching the bloodstream However, this systemic bioavailability may not directly reflect brain bioavailability (the amount reaching the central nervous system) Brain Penetration A critical distinction: systemic bioavailability (what enters the blood) differs from brain bioavailability (what crosses the blood-brain barrier and reaches neural tissue)